Skip to main content
NCBI home page
Protein Science : A Publication of the Protein Society logoLink to Protein Science : A Publication of the Protein Society
. 1998 May;7(5):1106–1115. doi: 10.1002/pro.5560070504

Hinge bending within the cytokine receptor superfamily revealed by the 2.4 A crystal structure of the extracellular domain of rabbit tissue factor.

Y A Muller 1, R F Kelley 1, A M de Vos 1
PMCID: PMC2144006  PMID: 9605315

Abstract

Tissue factor (TF), a member of the cytokine receptor superfamily, is the obligate cofactor of coagulation factor VIIa (FVIIa), and has a pivotal role in initiating the extrinsic pathway of blood coagulation through formation of the TF x FVIIa complex. The crystal structure of the extracellular portion of rabbit TF has been solved at 2.35 A resolution and refined to a crystallographic R-value of 19.1% (free R-value, 27.7%). Like the human homologue, the extracellular portion consists of two fibronectin type III domains connected by a short alpha-helical segment. Unexpectedly, the two molecules in the crystallographic asymmetric unit differ in their relative domain-domain orientation, revealing unsuspected hinge motion consisting of a rotation of about 12.7 degrees around an axis intersecting the linker segment at residue 106. Superposition of rabbit tissue factor with free and bound human tissue factor allows for the detection of an identical, albeit smaller, hinge motion in human TF induced upon binding of FVIIa. This raises the possibility that a very similar hinge axis may be present in other members of the cytokine receptor superfamily.

Full Text

The Full Text of this article is available as a PDF (6.6 MB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Banner D. W., D'Arcy A., Chène C., Winkler F. K., Guha A., Konigsberg W. H., Nemerson Y., Kirchhofer D. The crystal structure of the complex of blood coagulation factor VIIa with soluble tissue factor. Nature. 1996 Mar 7;380(6569):41–46. doi: 10.1038/380041a0. [DOI] [PubMed] [Google Scholar]
  2. Bazan J. F. Structural design and molecular evolution of a cytokine receptor superfamily. Proc Natl Acad Sci U S A. 1990 Sep;87(18):6934–6938. doi: 10.1073/pnas.87.18.6934. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bode W., Mayr I., Baumann U., Huber R., Stone S. R., Hofsteenge J. The refined 1.9 A crystal structure of human alpha-thrombin: interaction with D-Phe-Pro-Arg chloromethylketone and significance of the Tyr-Pro-Pro-Trp insertion segment. EMBO J. 1989 Nov;8(11):3467–3475. doi: 10.1002/j.1460-2075.1989.tb08511.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bom V. J., Bertina R. M. The contributions of Ca2+, phospholipids and tissue-factor apoprotein to the activation of human blood-coagulation factor X by activated factor VII. Biochem J. 1990 Jan 15;265(2):327–336. doi: 10.1042/bj2650327. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Bork P., Doolittle R. F. Proposed acquisition of an animal protein domain by bacteria. Proc Natl Acad Sci U S A. 1992 Oct 1;89(19):8990–8994. doi: 10.1073/pnas.89.19.8990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Bourell J. H., Clauser K. P., Kelley R., Carter P., Stults J. T. Electrospray ionization mass spectrometry of recombinantly engineered antibody fragments. Anal Chem. 1994 Jul 1;66(13):2088–2095. doi: 10.1021/ac00085a026. [DOI] [PubMed] [Google Scholar]
  7. Brünger A. T., Kuriyan J., Karplus M. Crystallographic R factor refinement by molecular dynamics. Science. 1987 Jan 23;235(4787):458–460. doi: 10.1126/science.235.4787.458. [DOI] [PubMed] [Google Scholar]
  8. Davie E. W., Fujikawa K., Kisiel W. The coagulation cascade: initiation, maintenance, and regulation. Biochemistry. 1991 Oct 29;30(43):10363–10370. doi: 10.1021/bi00107a001. [DOI] [PubMed] [Google Scholar]
  9. Dickinson C. D., Kelly C. R., Ruf W. Identification of surface residues mediating tissue factor binding and catalytic function of the serine protease factor VIIa. Proc Natl Acad Sci U S A. 1996 Dec 10;93(25):14379–14384. doi: 10.1073/pnas.93.25.14379. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Gerstein M., Lesk A. M., Chothia C. Structural mechanisms for domain movements in proteins. Biochemistry. 1994 Jun 7;33(22):6739–6749. doi: 10.1021/bi00188a001. [DOI] [PubMed] [Google Scholar]
  11. Harlos K., Martin D. M., O'Brien D. P., Jones E. Y., Stuart D. I., Polikarpov I., Miller A., Tuddenham E. G., Boys C. W. Crystal structure of the extracellular region of human tissue factor. Nature. 1994 Aug 25;370(6491):662–666. doi: 10.1038/370662a0. [DOI] [PubMed] [Google Scholar]
  12. Higashi S., Matsumoto N., Iwanaga S. Molecular mechanism of tissue factor-mediated acceleration of factor VIIa activity. J Biol Chem. 1996 Oct 25;271(43):26569–26574. doi: 10.1074/jbc.271.43.26569. [DOI] [PubMed] [Google Scholar]
  13. Huang M., Syed R., Stura E. A., Stone M. J., Stefanko R. S., Ruf W., Edgington T. S., Wilson I. A. The mechanism of an inhibitory antibody on TF-initiated blood coagulation revealed by the crystal structures of human tissue factor, Fab 5G9 and TF.G9 complex. J Mol Biol. 1998 Feb 6;275(5):873–894. doi: 10.1006/jmbi.1997.1512. [DOI] [PubMed] [Google Scholar]
  14. Huber A. H., Wang Y. M., Bieber A. J., Bjorkman P. J. Crystal structure of tandem type III fibronectin domains from Drosophila neuroglian at 2.0 A. Neuron. 1994 Apr;12(4):717–731. doi: 10.1016/0896-6273(94)90326-3. [DOI] [PubMed] [Google Scholar]
  15. Jones T. A., Zou J. Y., Cowan S. W., Kjeldgaard M. Improved methods for building protein models in electron density maps and the location of errors in these models. Acta Crystallogr A. 1991 Mar 1;47(Pt 2):110–119. doi: 10.1107/s0108767390010224. [DOI] [PubMed] [Google Scholar]
  16. Kelley R. F., Costas K. E., O'Connell M. P., Lazarus R. A. Analysis of the factor VIIa binding site on human tissue factor: effects of tissue factor mutations on the kinetics and thermodynamics of binding. Biochemistry. 1995 Aug 22;34(33):10383–10392. doi: 10.1021/bi00033a009. [DOI] [PubMed] [Google Scholar]
  17. Kelley R. F., Refino C. J., O'Connell M. P., Modi N., Sehl P., Lowe D., Pater C., Bunting S. A soluble tissue factor mutant is a selective anticoagulant and antithrombotic agent. Blood. 1997 May 1;89(9):3219–3227. [PubMed] [Google Scholar]
  18. Kossiakoff A. A., Somers W., Ultsch M., Andow K., Muller Y. A., De Vos A. M. Comparison of the intermediate complexes of human growth hormone bound to the human growth hormone and prolactin receptors. Protein Sci. 1994 Oct;3(10):1697–1705. doi: 10.1002/pro.5560031008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Matthews B. W. Solvent content of protein crystals. J Mol Biol. 1968 Apr 28;33(2):491–497. doi: 10.1016/0022-2836(68)90205-2. [DOI] [PubMed] [Google Scholar]
  20. Morrissey J. H., Fakhrai H., Edgington T. S. Molecular cloning of the cDNA for tissue factor, the cellular receptor for the initiation of the coagulation protease cascade. Cell. 1987 Jul 3;50(1):129–135. doi: 10.1016/0092-8674(87)90669-6. [DOI] [PubMed] [Google Scholar]
  21. Muller Y. A., Ultsch M. H., Kelley R. F., de Vos A. M. Structure of the extracellular domain of human tissue factor: location of the factor VIIa binding site. Biochemistry. 1994 Sep 13;33(36):10864–10870. doi: 10.1021/bi00202a003. [DOI] [PubMed] [Google Scholar]
  22. Muller Y. A., Ultsch M. H., de Vos A. M. The crystal structure of the extracellular domain of human tissue factor refined to 1.7 A resolution. J Mol Biol. 1996 Feb 16;256(1):144–159. doi: 10.1006/jmbi.1996.0073. [DOI] [PubMed] [Google Scholar]
  23. Nemerson Y. Tissue factor: then and now. Thromb Haemost. 1995 Jul;74(1):180–184. [PubMed] [Google Scholar]
  24. Røttingen J. A., Enden T., Camerer E., Iversen J. G., Prydz H. Binding of human factor VIIa to tissue factor induces cytosolic Ca2+ signals in J82 cells, transfected COS-1 cells, Madin-Darby canine kidney cells and in human endothelial cells induced to synthesize tissue factor. J Biol Chem. 1995 Mar 3;270(9):4650–4660. doi: 10.1074/jbc.270.9.4650. [DOI] [PubMed] [Google Scholar]
  25. Scarpati E. M., Wen D., Broze G. J., Jr, Miletich J. P., Flandermeyer R. R., Siegel N. R., Sadler J. E. Human tissue factor: cDNA sequence and chromosome localization of the gene. Biochemistry. 1987 Aug 25;26(17):5234–5238. doi: 10.1021/bi00391a004. [DOI] [PubMed] [Google Scholar]
  26. Taylor F. B., Jr, Chang A., Ruf W., Morrissey J. H., Hinshaw L., Catlett R., Blick K., Edgington T. S. Lethal E. coli septic shock is prevented by blocking tissue factor with monoclonal antibody. Circ Shock. 1991 Mar;33(3):127–134. [PubMed] [Google Scholar]
  27. Walter M. R., Windsor W. T., Nagabhushan T. L., Lundell D. J., Lunn C. A., Zauodny P. J., Narula S. K. Crystal structure of a complex between interferon-gamma and its soluble high-affinity receptor. Nature. 1995 Jul 20;376(6537):230–235. doi: 10.1038/376230a0. [DOI] [PubMed] [Google Scholar]
  28. Wells J. A., de Vos A. M. Hematopoietic receptor complexes. Annu Rev Biochem. 1996;65:609–634. doi: 10.1146/annurev.bi.65.070196.003141. [DOI] [PubMed] [Google Scholar]
  29. Zioncheck T. F., Roy S., Vehar G. A. The cytoplasmic domain of tissue factor is phosphorylated by a protein kinase C-dependent mechanism. J Biol Chem. 1992 Feb 25;267(6):3561–3564. [PubMed] [Google Scholar]

Articles from Protein Science : A Publication of the Protein Society are provided here courtesy of The Protein Society

RESOURCES